These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 20538518

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Characterization of the katG, inhA, ahpC, kasA, and oxyR gene mutations in isoniazid-resistant and susceptible strain of Mycobacterium tuberculosis by automated DNA sequencing].
    Chen X, Ma Y, Jin Q, Jiang GL, Li CY, Wang Q.
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Apr; 28(4):250-3. PubMed ID: 15854436
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation.
    Afanas'ev MV, Ikryannikova LN, Il'ina EN, Sidorenko SV, Kuz'min AV, Larionova EE, Smirnova TG, Chernousova LN, Kamaev EY, Skorniakov SN, Kinsht VN, Cherednichenko AG, Govorun VM.
    J Antimicrob Chemother; 2007 Jun; 59(6):1057-64. PubMed ID: 17442757
    [Abstract] [Full Text] [Related]

  • 5. Rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis strains isolated from patients in Kazakhstan.
    Hillemann D, Kubica T, Agzamova R, Venera B, Rüsch-Gerdes S, Niemann S.
    Int J Tuberc Lung Dis; 2005 Oct; 9(10):1161-7. PubMed ID: 16229229
    [Abstract] [Full Text] [Related]

  • 6. Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan.
    Kozhamkulov U, Akhmetova A, Rakhimova S, Belova E, Alenova A, Bismilda V, Chingissova L, Ismailov S, Ramanculov E, Momynaliev K.
    Jpn J Infect Dis; 2011 Oct; 64(3):253-5. PubMed ID: 21617314
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens.
    Hillemann D, Rüsch-Gerdes S, Richter E.
    J Clin Microbiol; 2007 Aug; 45(8):2635-40. PubMed ID: 17537937
    [Abstract] [Full Text] [Related]

  • 9. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical strains isolated in the Philippines.
    Herrera L, Valverde A, Saiz P, Sáez-Nieto JA, Portero JL, Jiménez MS.
    Int J Antimicrob Agents; 2004 Jun; 23(6):572-6. PubMed ID: 15194127
    [Abstract] [Full Text] [Related]

  • 10. Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis.
    Ando H, Kitao T, Miyoshi-Akiyama T, Kato S, Mori T, Kirikae T.
    Mol Microbiol; 2011 Mar; 79(6):1615-28. PubMed ID: 21244531
    [Abstract] [Full Text] [Related]

  • 11. Genomic mutations in the katG, inhA and aphC genes are useful for the prediction of isoniazid resistance in Mycobacterium tuberculosis isolates from Kwazulu Natal, South Africa.
    Kiepiela P, Bishop KS, Smith AN, Roux L, York DF.
    Tuber Lung Dis; 2000 Mar; 80(1):47-56. PubMed ID: 10897383
    [Abstract] [Full Text] [Related]

  • 12. Detection of multidrug resistance in Mycobacterium tuberculosis.
    Sekiguchi J, Miyoshi-Akiyama T, Augustynowicz-Kopeć E, Zwolska Z, Kirikae F, Toyota E, Kobayashi I, Morita K, Kudo K, Kato S, Kuratsuji T, Mori T, Kirikae T.
    J Clin Microbiol; 2007 Jan; 45(1):179-92. PubMed ID: 17108078
    [Abstract] [Full Text] [Related]

  • 13. A pyrosequencing method for molecular monitoring of regions in the inhA, ahpC and rpoB genes of Mycobacterium tuberculosis.
    Garza-González E, González GM, Rentería A, Cruz-Pulido W, Rivera G, Bocanegra-García V.
    Clin Microbiol Infect; 2010 Jun; 16(6):607-12. PubMed ID: 19673965
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates.
    Hillemann D, Weizenegger M, Kubica T, Richter E, Niemann S.
    J Clin Microbiol; 2005 Aug; 43(8):3699-703. PubMed ID: 16081898
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates.
    Mokrousov I, Bhanu NV, Suffys PN, Kadival GV, Yap SF, Cho SN, Jordaan AM, Narvskaya O, Singh UB, Gomes HM, Lee H, Kulkarni SP, Lim KC, Khan BK, van Soolingen D, Victor TC, Schouls LM.
    J Microbiol Methods; 2004 Jun; 57(3):323-35. PubMed ID: 15134881
    [Abstract] [Full Text] [Related]

  • 19. Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex.
    Shenai S, Rodrigues C, Mehta A.
    Int J Infect Dis; 2009 Jan; 13(1):46-58. PubMed ID: 18565777
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.